References

Gut microbiota in overweight and obesity: crosstalk with adipose tissue

10.1038/s41575-023-00867-z · 2024 · External reference

Brown adipose tissue is associated with cardiometabolic health

10.1038/s41591-020-1126-7 · 2021 · External reference

Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials

10.1093/cid/ciz999 · 2020 · External reference

HIV and antiretroviral therapy-related fat alterations

10.1038/s41572-020-0181-1 · 2020 · External reference

Recent data on adipose tissue, insulin resistance, diabetes and dyslipidaemia in antiretroviral therapy controlled HIV-infected persons

10.1097/coh.0000000000000674 · 2021 · External reference

Trends in weight change patterns across life course among US adults, 1988-2018; population-based study

10.1186/s12889-023-17137-x · 2023 · External reference

HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir

10.1038/s43856-026-01405-z · 2026 · External reference

Effect of metabolic status on response to SIV infection and antiretroviral therapy in nonhuman primates

10.1172/jci.insight.181968 · 2024 · External reference

Tenofovir alafenamide promotes weight gain and impairs fatty acid metabolism-related signaling pathways in visceral fat tissue compared to tenofovir disoproxil fumarate

10.1016/j.antiviral.2025.106151 · 2025 · External reference

12-week dolutegravir treatment marginally reduces energy expenditure but does not increase body weight or alter vascular function in a murine model of Human Immunodeficiency Virus infection

10.1016/j.vph.2024.107288 · 2024 · External reference

Lipodystrophy in HIV: evolving challenges and unresolved questions

10.3390/ijms26146546 · 2025 · External reference

Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV

10.1097/qad.0000000000004131 · 2025 · External reference

Low CD4 counts predict excessive weight gains during first-line treatment for HIV

10.1093/jac/dkae238 · 2024 · External reference

Residual immune dysfunction under antiretroviral therapy

10.1016/j.smim.2021.101471 · 2021 · External reference

The integrase inhibitors dolutegravir and raltegravir exert pro-adipogenic and profibrotic effects and induce insulin resistance in human/simian adipose tissue and human adipocytes

10.1093/cid/ciaa259 · 2020 · External reference

Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function

10.1016/j.bcp.2023.116010 · 2024 · External reference

A distinct form of fat fibrosis is linked to insulin resistance in people with HIV

2026 · External reference

Inhibition of adipose tissue beiging by HIV integrase inhibitors, dolutegravir and bictegravir, is associated with adipocyte hypertrophy, hypoxia, elevated fibrosis, and insulin resistance in simian adipose tissue and human adipocytes

10.3390/cells11111841 · 2022 · External reference

Adipocyte differentiation of 3T3-L1 cells under tenofovir alafenamide, tenofovir disoproxil fumarate, and integrase strand transfer inhibitors selective challenge: an in-vitro model

10.1097/qad.0000000000003455 · 2023 · External reference

Dolutegravir suppresses thermogenesis via disrupting uncoupling protein 1 expression and mitochondrial function in brown/beige adipocytes in preclinical models

10.1093/infdis/jiac175 · 2022 · External reference

Differential adipose tissue remodeling and metabolic effects of dolutegravir and bictegravir: implications for HIV therapy

10.1016/j.biopha.2025.118831 · 2025 · External reference

Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa

10.1002/jia2.26268 · 2024 · External reference

The primacy of adipose tissue gene expression and plasma lipidome in cardiometabolic disease in persons with HIV

10.1093/infdis/jiae532 · 2025 · External reference

Single-cell analysis of subcutaneous fat reveals profibrotic cells that correlate with visceral adiposity in HIV

10.1210/clinem/dgae369 · 2024 · External reference

Changes in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIV

10.3389/fimmu.2023.1152003 · 2023 · External reference

Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised double-blind, placebo-controlled phase 2b single-centre clinical trial

10.1016/s2213-8587(24)00150-5 · 2024 · External reference

Weight loss associated with semaglutide treatment among people with HIV

10.1097/qad.0000000000003791 · 2024 · External reference

Glucagon-like peptide 1 receptor agonists promote weight loss among people with HIV

10.1093/cid/ciae151 · 2024 · External reference

How does bariatric surgery remodel adipose tissue?

10.1016/j.ando.2024.05.008 · 2024 · External reference